News Conference News CRT 2025 AGENT IDE: DCB Performance for In-Stent Restenosis Lasts Out to 2 Years L.A. McKeown March 10, 2025
News Conference News CRT 2024 Mixed Bag With DCBs for In-Stent Restenosis, Small Coronary Arteries L.A. McKeown March 14, 2024
News Conference News CRT 2024 Full AGENT IDE Results Affirm Benefits of DCB for In-Stent Restenosis L.A. McKeown March 09, 2024
News Conference News BIOFLOW V: Orsiro Still Offers Some Benefits at 5 Years Caitlin E. Cox March 02, 2022
News Conference News CRT 2021 Polymer-Free Stent Noninferior to ZES at 3 Years: ReCre8 Yael L. Maxwell March 18, 2021
News Daily News CRT 2021 COMPARE-ABSORB: 3-Year Results Hint at Stabilization With Bioresorbable Scaffold Michael O'Riordan March 17, 2021
News Conference News CRT 2021 BIOSTEMI at 2 Years: Orsiro Continues to Lower TLF in STEMI Patients Caitlin E. Cox March 16, 2021
News Conference News CRT 2020 Newer, Thinner-Strut Abbott Scaffold Prompts Talk of a BVS Comeback Michael O'Riordan February 28, 2020
News Conference News CRT 2020 BIOFLOW V: Orsiro Bests Xience at 3 Years for TLF, Late Stent Thrombosis L.A. McKeown February 25, 2020
News Conference News CRT 2018 Wait Continues for a Win With Biodegradable-Polymer DES in Patients at High Bleeding Risk: BIO-RESORT Michael O'Riordan March 08, 2018
News Conference News CRT 2017 Absorb BVS: Better Technique, Better Outcomes? More Data—and More Debate Michael O'Riordan February 21, 2017
News Conference News CRT 2016 Registry Behind TASTE Reopens Thrombus Aspiration Question With New Analysis of Stent Thrombosis Shelley Wood February 22, 2016
News Conference News CRT 2016 Early Results for Transcatheter Mitral Valve Replacement Reveal Complications and Challenges for the Long Road Ahead Shelley Wood February 21, 2016